GGrantIndex
Sort

46,585 grants matching heart failure

Myocardial Injury Associated with Mitochondria-Derived Oxygen Free Radical(s)

$379,601
Yeong-Renn Chen · Northeast Ohio Medical University · R01 · FY2016 · HL

Multiscale Modeling of Right Ventricular Fibrotic Remodeling in Pulmonary Arterial Hypertension

$379,563
Daniela Valdez-Jasso · University Of California, San Diego · R01 · FY2025 · HL

Multifaceted Prospective Memory Intervention to Improve Medication Adherence

$379,558
Kathleen C Insel · University Of Arizona · R01 · FY2011 · NR

A Bioactive Prosthetic Vascular Graft

$379,528
Matthew Douglas Phaneuf · Biosurfaces · R42 · FY2011 · HL

Angiogenesis, Cardiac Hypertrophy and Surgical Ischemia

$379,508
Children'S Hospital Boston · R01 · FY2005 · HL

Oxidative Response Networks in Chagasic Cardiomyopathy

$379,500
Nisha Jain Garg · University Of Texas Med Br Galveston · R01 · FY2009 · HL

Cardiac surgery techniques to treat ventricular and aortic remodeling

$379,495
Michael Andrew Acker · University Of Pennsylvania · U01 · FY2008 · HL

Development of Poloxamer-188 for the Treatment of Muscular Dystrophy Associated H

$379,487
Bruce E. Markham · Phrixus Pharmaceuticals, Inc. · R43 · FY2009 · HL

Mass Spectrometry of Proteins Involved in Organogenesis (5 of 10)

$379,467
Shamil Sunyaev · Brigham And Women'S Hospital · RL1 · FY2010 · DE

ANGIOGENIC TISSUE ENGINEERING TO LIMIT POST-INFARCTION VENTRICULAR REMODELING

$379,465
Y Joseph Woo · Stanford University · R01 · FY2014 · HL

Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury

$379,444
Mingming Ning · Massachusetts General Hospital · R01 · FY2012 · NS

Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury

$379,444
Mingming Ning · Massachusetts General Hospital · R01 · FY2011 · NS

Integrating Costs Into Shared Decision-Making for Heart Failure with Reduced Ejection Fraction

$379,442
Neal Workman Dickert · Emory University · R01 · FY2022 · HS

Mitochondrial Protein HSG (Mfn-2) Is A Primary Mediator of Oxidative Apoptosis

$379,424
Rui-Ping Xiao · National Institute On Aging · Z01 · FY2008 · AG

B-Arrestin2 Is Required for BAR Resensitization But Not its Desensitization

$379,424
Rui-Ping Xiao · National Institute On Aging · Z01 · FY2008 · AG

Natriuretic Peptide System as Therapy in Human Preclinical LV Dysfunction

$379,411
Horng H Chen · Mayo Clinic Rochester · P01 · FY2008 · HL

Translational Development of Novel MMP Inhibitors

$379,406
Seth M Cohen · University Of California, San Diego · R01 · FY2008 · HL

Novel Zinc-Nanocomposite Materials for Pediatric Bioresorbable Cardiovascular Stents

$379,385
Benjamin M Wu · University Of California Los Angeles · R01 · FY2019 · HL

Role of Rbfox2 in hypoplastic left heart syndrome

$379,379
Muge N Kuyumcu-Martinez · University Of Texas Med Br Galveston · R01 · FY2018 · HL

Roles of FGF2 and TGFbeta in cardiac hypertrophy

$379,373
University Of Cincinnati · R01 · FY2002 · HL

Cardiomyocyte Zinc and its Regulation of Contraction-Relaxation Function

$379,356
Bradley M Palmer · University Of Vermont & St Agric College · R01 · FY2010 · HL

p66Shc Signaling Functions in Cardiomyocytes

$379,348
Susan F Steinberg · Columbia University Health Sciences · R01 · FY2013 · HL

Endothelial Oxidative Stress and Inflammation:Mechanisms and Human Studies

$379,348
Paolo C Colombo · Columbia University Health Sciences · R01 · FY2013 · HL

The Dynamics of Human Atrial Fibrillation

$379,333
Sanjiv M Narayan · University Of California, San Diego · R01 · FY2011 · HL

Heart and Skeletal Muscle Metabolism, Energetics and Function in Barth Syndrome

$379,329
William Todd Cade · Washington University · R01 · FY2016 · HL